Visit to SH-STIC and Biotech Companies in Shenzhen

On 4 December 2024, senior management from Nan Fung Group and HKLSS visited Shenzhen to engage in productive discussions with Shenzhen-Hong Kong Science and Technology Innovation Co-operation Zone Development Co. (SH-STIC), Signet Therapeutics, and XtalPi. The delegation was led by Mr Vincent Cheung, Founder and Board Chair of HKLSS, as well as CEO of Nan Fung Group. 

The primary objective of this visit was to explore and further develop collaborative opportunities, including summer internships in Shenzhen, thereby reinforcing our commitment to cross-border collaboration and the attraction and retention of talent in the Greater Bay Area (GBA).